Atlas Trials

Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma

Clinical trial NCT01278940 · COMPLETED

Trial details

NCT number
NCT01278940
Sponsor
Oslo University Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2002-03-01
Primary completion
2006-02-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.